CDNA
Overvalued by 106.5% based on the discounted cash flow analysis.
Market cap | $946.01 Million |
---|---|
Enterprise Value | $857.27 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $1 |
Beta | 2.28 |
Outstanding Shares | 55,262,459 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 15.95 |
---|---|
PEG | -42.14 |
Price to Sales | 2.83 |
Price to Book Ratio | 2.83 |
Enterprise Value to Revenue | 2.47 |
Enterprise Value to EBIT | 18.28 |
Enterprise Value to Net Income | 14 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data